Title of article :
Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSista
Author/Authors :
Charles B Hicks، نويسنده , , Pedro Cahn، نويسنده , , David A Cooper، نويسنده , , Sharon L Walmsley، نويسنده , , Christine Katlama، نويسنده , , Bonaventura Clotet، نويسنده , , Adriano Lazzarin، نويسنده , , Margaret T. Johnson-Selfridge، نويسنده , , Dietmar Neubacher، نويسنده , , Douglas Mayers، نويسنده , , Hernan Valdez ، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2007
Pages :
10
From page :
466
To page :
475
Abstract :
Background Treatment options for HIV-1 infected individuals who have received extensive previous antiretroviral therapy are limited. We compared efficacy and safety of the novel non-peptidic protease inhibitor tipranavir co-administered with ritonavir plu
Journal title :
The Lancet
Serial Year :
2007
Journal title :
The Lancet
Record number :
590040
Link To Document :
https://search.isc.ac/dl/search/defaultta.aspx?DTC=10&DC=590040
بازگشت